RS

Rajesh Singh

Active Director Director DIN 07585375
DIN 07585375 First appointment Feb 2017 Primary industry Food And Beverages
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value •••• Premium profile

About Rajesh Singh

Data last updated:

Rajesh Singh is a Director at Raxmo Pharma Private Limited (since 2017). The company operates in Food And Beverages. Raxmo Pharma Private Limited reported revenue of ₹1.5 Lakh (FY 2019).

DIN 07585375
Primary Designation Director
Industry Food And Beverages
First Appointment 07 Feb 2017
Oldest Company Age 9 yrs
Largest company Raxmo Pharma Private Limited · ₹1.5 Lakh (FY 2019)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Raxmo Pharma Private Limited U24304UP2017PTC090172
Director07 Feb 20172017₹1.5 Lakh (FY 2019)Active

Board colleagues of Rajesh Singh

NameDINCompanyDesignation
Mala Singh07309930Raxmo Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Raxmo Pharma Private Limited
Premium access

Shareholding and investment profile for Rajesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Singh

Rajesh Singh currently holds 1 directorship: Raxmo Pharma Private Limited (Director, since 07 Feb 2017, revenue ₹1.5 Lakh (FY 2019)).

Rajesh Singh was first appointed on 07 Feb 2017 as Director at Raxmo Pharma Private Limited.

The current boards of Rajesh Singh's companies include Mala Singh (Raxmo Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available